TechConnect Innovation Program

Nanocarriers for intracellular protein and peptide‐based drug delivery

Tufts University, Massachusetts, United States

TECHNOLOGY SUMMARY

This opportunity provides an intracellular lipid‐mediated formulation for protein delivery to cells. This proprietary composition offers a traceless method for intracellular delivery of any protein drug. This new discovery will pave the way for delivery of an emerging class of antibody and protein therapeutics.

Primary Application Area: Biotech & Biological Sciences

Technology Development Status: Prototype

Technology Readiness Level: TRL 4

FIGURES OF MERIT

Value Proposition: Benefits of this technology compared to other liposomal delivery systems include that it is applicable to any protein therapeutic, it utilizes a cost-effective methodology for scalable synthesis of lipids, it provides a traceless delivery method, and it involves broadly-applicable nanocomplexes similar to those already used by companies for RNAi delivery.

SHOWCASE SUMMARY

Organization Type: Academic/Gov Lab

Showcase Booth #: 637

Website: techtransfer.tufts.edu

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date:

Primary Sources of Funding: University

Looking for: Both Funding and Development Partners